The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Perez, L. E.
Right arrow Articles by Melby, P. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Perez, L. E.
Right arrow Articles by Melby, P. C.
The Journal of Immunology, 2006, 176: 5519-5528.
Copyright © 2006 by The American Association of Immunologists

Reduced Nitric Oxide Synthase 2 (NOS2) Promoter Activity in the Syrian Hamster Renders the Animal Functionally Deficient in NOS2 Activity and Unable to Control an Intracellular Pathogen1

Luis E. Perez*,{dagger}, Bysani Chandrasekar*,{dagger}, Omar A. Saldarriaga{dagger},{ddagger}, Weiguo Zhao*,{dagger}, Lourdes T. Arteaga*,{dagger}, Bruno L. Travi§ and Peter C. Melby2,*,{dagger},{ddagger}

* Research Service, Department of Veterans Affairs Medical Center, South Texas Veterans Health Care System, San Antonio, TX 78229; Departments of {dagger} Medicine and {ddagger} Microbiology and Immunology, University of Texas Health Science Center, San Antonio, TX 78229; and § Centro Internacional de Entrenamiento e Investigaciones Medicas, Cali, Colombia

Progressive disease in the hamster model of visceral leishmaniasis, caused by Leishmania donovani, in contrast to infection in mice, mimics the progressive disease observed in untreated humans. During progressive infection in hamsters, there was a vigorous type 1 cellular immune response, which is typically associated with control of infection, suggesting that there was ineffective IFN-{gamma}-mediated macrophage activation. Indeed, at the site of infection, hamsters did not express NO synthase 2 (NOS2), which is the primary mechanism for control of infection in mice. Furthermore, in striking contrast to mouse macrophages, IFN-{gamma}-activated hamster macrophages did not did not express NOS2 nor generate NO, and were unable to restrict the replication of intracellular L. donovani. The absent hamster NOS2 expression was not the result of NOS2 gene deletion and the NOS2 cDNA had an intact open reading frame. Furthermore, the impaired transcription of NOS2 mRNA was selective and not due to global impairment of IFN-{gamma} signaling (members of the IFN-{gamma}-signaling pathway were expressed and functional and IFN-{gamma} up-regulated several primary and secondary response genes). Strikingly, the proximal hamster NOS2 promoter, like the human ortholog, had >20-fold less basal and IFN-{gamma}/LPS-inducible activity than the corresponding mouse promoter. Thus, reduced basal and IFN-{gamma}-induced activity of the hamster NOS2 transcriptional unit, which is unique to this small animal and similar to the human counterpart, accompanies the inability of the animal to control an intracellular pathogen.




This article has been cited by other articles:


Home page
Infect. Immun.Home page
B. Dondji, R. D. Bungiro, L. M. Harrison, J. J. Vermeire, C. Bifulco, D. McMahon-Pratt, and M. Cappello
Role for Nitric Oxide in Hookworm-Associated Immune Suppression
Infect. Immun., June 1, 2008; 76(6): 2560 - 2567.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
Y. Osorio, D. L. Bonilla, A. G. Peniche, P. C. Melby, and B. L. Travi
Pregnancy enhances the innate immune response in experimental cutaneous leishmaniasis through hormone-modulated nitric oxide production
J. Leukoc. Biol., June 1, 2008; 83(6): 1413 - 1422.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
M. Schneemann and G. Schoeden
Macrophage biology and immunology: man is not a mouse
J. Leukoc. Biol., March 1, 2007; 81(3): 579 - 579.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2006 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2006 by The American Association of Immunologists, Inc. All rights reserved.